| Current Price | $1.10 | Mkt Cap | $533.4M |
|---|---|---|---|
| Open | $1.10 | P/E Ratio | -2.02 |
| Prev. Close | $1.10 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.08 - $1.12 | Volume | 1,411,973 |
| 52-Wk Range | $0.71 - $2.10 | Avg. Daily Vol. | 7,157,527 |
| Current Price | $1.10 | Mkt Cap | $533.4M |
|---|---|---|---|
| Open | $1.10 | P/E Ratio | -2.02 |
| Prev. Close | $1.10 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.08 - $1.12 | Volume | 1,411,973 |
| 52-Wk Range | $0.71 - $2.10 | Avg. Daily Vol. | 7,157,527 |
The best Bull and Bear pitches based on recency and number of recommendations.
Stock squeeze will run out of steam and crash
Read the most recent pitches from players about CLOV.
Recs
jisifu
(< 20)
Submitted: 2/22/2022 1:24:15 AM :
Start Price:
$9.77
NASDAQ:CLOV Score:
-101.25
I started writing a few articles on hc and tech changes.
https://clovchronicles.substack.com/
basically, clover has a huge TAM and a differentiable product and business model that has a durable sustainable advantage to their larger competition. The clover assistant is a software that presents useful information to the doctor about a patient and it's a bigger deal that one thinks when it comes to detecting diseases and making sure screening is regular.
it's really an interesting approach where an insurer is taking a proactive approach in preventive precision medicine.
Biggest difference from last year and this year is that they have 20+ patents now to solidify their technological moat. the patents give clover an opportunity to pave way to a new wave of adoption for info tech organizing capabilities by physicians.
lives that are managed by their software are +20% in gross margin over their counterparts who dont use the software. this is promising since the industry is known for relatively low margins between 10-15% with debt burden.
Recs
Margaritarius
(< 20)
Submitted: 1/23/2022 12:06:24 AM :
Start Price:
$2.37
NASDAQ:CLOV Score:
-53.12
Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for these companies to accelerate their expansion into positive cash flows or outright profit margin; Clover is one such company; With a total debt to capital ratio of 4.61%, reported last Sept, she's operating at 1/10th the average debt ratio in her industry; Pretty smart move ahead of climbing interest rates if you ask me; CLOV also grew revenue 89% in the 3rd quarter as she expands her AI-enabled Medicare Advantage services into new states steadily stealing market share from the broader industry; Palihapatiya’s pick uses AI to bring providers and patients together; Providers actually recommend plans to patients so that they can get the care they need; Brilliant! It’s also recession proof; I’m likely to pass on a new EV when things get tight, but I’m pretty sure I’ll spring for coverage to get the health care I need to stay alive
Recs
link8822
(74.63)
Submitted: 6/10/2021 1:32:01 AM :
Start Price:
$18.09
NASDAQ:CLOV Score:
+95.68
Stock squeeze will run out of steam and crash
Find the members with the highest scoring picks in CLOV.
TMFBwithbike (45.04) Score: +267.54
The Score Leader is the player with the highest score across all their picks in CLOV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TMFjimhalley | < 20 | 3/12/2021 |
|
1Y | $8.80 | -87.50% | +9.39% | +96.89 | 1 Comment | |
| link8822 | 74.63 | 6/10/2021 |
|
1Y | $18.09 | -93.92% | +1.76% | +95.68 | 1 Comment | |
| TMFdjagielski | 37.94 | 6/14/2021 |
|
5Y | $14.65 | -92.49% | +1.41% | +93.90 | 0 Comment | |
| baf72167 | < 20 | 6/21/2021 |
|
5Y | $11.40 | -90.35% | +2.52% | +92.87 | 0 Comment | |
| kkconway | 98.96 | 8/9/2023 |
|
5Y | $1.54 | -28.57% | -4.14% | -24.43 | 0 Comment | |
|
Margaritarius | < 20 | 1/24/2022 |
|
5Y | $2.37 | -53.49% | -0.37% | -53.12 | 1 Comment |
| Playa17 | < 20 | 10/5/2022 |
|
5Y | $1.83 | -39.89% | +15.27% | -55.16 | 0 Comment | |
| MexicanFool99 | 61.73 | 1/7/2022 |
|
5Y | $3.31 | -66.77% | -8.02% | -58.75 | 0 Comment | |
| lancealot1972 | < 20 | 9/20/2022 |
|
5Y | $2.17 | -49.31% | +11.78% | -61.09 | 0 Comment | |
| angelawirya | < 20 | 1/5/2022 |
|
5Y | $3.86 | -71.50% | -9.80% | -61.71 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
